Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naive Patients With Type 2 Diabetes

Conclusions: The dulaglutide single-dose pen was found to be a safe and effective device for use by patients with T2D who were injection-naïve. A positive injection experience is an important factor for patients and providers when initiating injectable therapy.

http://dst.sagepub.com/cgi/content/abstract/9/5/1071?rss=1

Source: Journal of Diabetes Science and Technology - September 1, 2015 Category: Endocrinology Authors: Matfin, G., Van Brunt, K., Zimmermann, A. G., Threlkeld, R., Ignaut, D. A. Tags: Original Articles Source Type: research